2Indexed trials
drug · Product Intelligence
Fenfluramine Hydrochloride
Pipeline Intelligence
Fenfluramine Hydrochloride: 2 indexed trials, 2 sponsors; 28 linked Orange Book patents and 4 FDA-linked events where matched.
2Sponsors
28Orange Book patent links
4FDA-linked events
Development evidence
NCT03780127Zogenix, Inc. · epilepsyAPPROVED_FOR_MARKETING
NCT03861871NYU Langone Health · out_of_scopePHASE2
FDA / patent evidence
10452815*PEDFINTEPLA · app 2121022038-12-29
10452815FINTEPLA · app 2121022038-06-29
11786487*PEDFINTEPLA · app 2121022038-02-02
10603290*PEDFINTEPLA · app 2121022038-02-02
11406606*PEDFINTEPLA · app 2121022038-02-02
11759440*PEDFINTEPLA · app 2121022038-02-02
11040018*PEDFINTEPLA · app 2121022038-02-02
11759440FINTEPLA · app 2121022037-08-02
10603290FINTEPLA · app 2121022037-08-02
11040018FINTEPLA · app 2121022037-08-02
11406606FINTEPLA · app 2121022037-08-02
11786487FINTEPLA · app 2121022037-08-02
Regulatory context
FDA_EXCLUSIVITYFINTEPLA · PED2029-09-25
FDA_EXCLUSIVITYFINTEPLA · ODE-3932029-03-25
FDA_EXCLUSIVITYFINTEPLA · ODE-3122027-06-25
FDA_APPROVALFINTEPLA · 2020-06-25
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.